Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Autore principale: | Forbes, E |
---|---|
Altri autori: | Hill, A |
Natura: | Tesi |
Lingua: | English |
Pubblicazione: |
2011
|
Soggetti: |
Documenti analoghi
Documenti analoghi
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
di: Kapulu, MC
Pubblicazione: (2014) -
Developing novel blood-stage malaria vaccines
di: Douglas, AD
Pubblicazione: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
di: Bauza, K
Pubblicazione: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
di: de Cassan, S
Pubblicazione: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
di: Elias, SC
Pubblicazione: (2014)